ICHNO-ECHNO 2022 | Potential of immunotherapy in head and neck cancer

Kevin Harrington, FRCP, FRCR, FRSB, PhD, The Institute of Cancer Research and Royal Marsden Hospital, London, UK, discusses the promising future of immunotherapy for patients with head and neck cancer. Prof. Harrington suggests that immunotherapy has the potential to provide curative treatment for some patients, but there is a lot more research to be done, such as studying why some patients have resistance to immunotherapy, what treatment schedule is best, and what combination therapies could achieve maximum benefit for patients. This interview took place at the joint International Congress on Innovative Approaches in Head and Neck Oncology and the European Congress on Head and Neck Oncology (ICHNO-ECHNO) 2022 hybrid meeting in Brussels, Belgium.